Athyrium资本管理与Esperion Therapeutics Inc. (NASDAQ: ESPR) 已签署一项价值5000万美元的日本特许权融资协议。此项融资旨在为Esperion Therapeutics战略性收购Corstasis Therapeutics提供资金支持。
Athyrium资本管理与Esperion Therapeutics Inc. (NASDAQ: ESPR) 已签署一项价值5000万美元的日本特许权融资协议。此项融资旨在为Esperion Therapeutics战略性收购Corstasis Therapeutics提供资金支持。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.